lamotrigine has been researched along with Anankastic Personality in 16 studies
Excerpt | Relevance | Reference |
---|---|---|
"The present 16-week double-blind, randomized, placebo-controlled trial had the aim to explore the efficacy of lamotrigine add-on pharmacotherapy on clinical symptomatology and cognitive functioning in a sample of patients with treatment-resistant obsessive-compulsive disorder (OCD) receiving serotonin reuptake inhibitors (SRIs)." | 9.16 | Lamotrigine augmentation of serotonin reuptake inhibitors in treatment-resistant obsessive-compulsive disorder: a double-blind, placebo-controlled study. ( Abenavoli, E; Bruno, A; D'Arrigo, C; Di Nardo, F; Mallamace, D; Micò, U; Muscatello, MR; Pandolfo, G; Spina, E; Zoccali, RA, 2012) |
"This study evaluated the efficacy and safety of lamotrigine in binge-eating disorder (BED) associated with obesity." | 9.14 | Lamotrigine in the treatment of binge-eating disorder with obesity: a randomized, placebo-controlled monotherapy trial. ( Guerdjikova, AI; Hudson, JI; Keck, PE; McElroy, SL; Nelson, E; Welge, JA, 2009) |
"IntroductionLamotrigine is a commonly used drug in the treatment of bipolar disorder." | 7.91 | Lamotrigine-induced obsessive-compulsive disorder in patients with bipolar disorder. ( Doobay, M; Sharma, V, 2019) |
"The present 16-week double-blind, randomized, placebo-controlled trial had the aim to explore the efficacy of lamotrigine add-on pharmacotherapy on clinical symptomatology and cognitive functioning in a sample of patients with treatment-resistant obsessive-compulsive disorder (OCD) receiving serotonin reuptake inhibitors (SRIs)." | 5.16 | Lamotrigine augmentation of serotonin reuptake inhibitors in treatment-resistant obsessive-compulsive disorder: a double-blind, placebo-controlled study. ( Abenavoli, E; Bruno, A; D'Arrigo, C; Di Nardo, F; Mallamace, D; Micò, U; Muscatello, MR; Pandolfo, G; Spina, E; Zoccali, RA, 2012) |
"This study evaluated the efficacy and safety of lamotrigine in binge-eating disorder (BED) associated with obesity." | 5.14 | Lamotrigine in the treatment of binge-eating disorder with obesity: a randomized, placebo-controlled monotherapy trial. ( Guerdjikova, AI; Hudson, JI; Keck, PE; McElroy, SL; Nelson, E; Welge, JA, 2009) |
"IntroductionLamotrigine is a commonly used drug in the treatment of bipolar disorder." | 3.91 | Lamotrigine-induced obsessive-compulsive disorder in patients with bipolar disorder. ( Doobay, M; Sharma, V, 2019) |
"Memantine was found to be most effective augmentation agent for SRIs in OCD, followed by lamotrigine, ondansetron and granisetron with moderate certainty of evidence." | 3.01 | Pharmacological augmentation of serotonin reuptake inhibitors in patients with obsessive-compulsive disorder: A network meta-analysis. ( Maiti, R; Mishra, A; Mishra, BR; Srinivasan, A, 2023) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (6.25) | 18.2507 |
2000's | 6 (37.50) | 29.6817 |
2010's | 8 (50.00) | 24.3611 |
2020's | 1 (6.25) | 2.80 |
Authors | Studies |
---|---|
Maiti, R | 1 |
Mishra, A | 1 |
Srinivasan, A | 1 |
Mishra, BR | 1 |
Sharma, V | 1 |
Doobay, M | 1 |
Jaffe, RJ | 2 |
Juneja, NS | 2 |
Coffey, BJ | 1 |
Szmulewicz, AG | 1 |
Valerio, MP | 1 |
Smith, JM | 1 |
Naguy, A | 1 |
Alamiri, B | 1 |
Al-Khadhari, S | 1 |
Francis, K | 1 |
Uzun, O | 1 |
Bisol, LW | 1 |
Lara, DR | 1 |
Moretti, M | 1 |
Guerdjikova, AI | 1 |
McElroy, SL | 1 |
Welge, JA | 1 |
Nelson, E | 1 |
Keck, PE | 1 |
Hudson, JI | 1 |
Mahgoub, N | 1 |
Asemota, B | 1 |
Alexopoulos, GS | 1 |
Bruno, A | 1 |
Micò, U | 1 |
Pandolfo, G | 1 |
Mallamace, D | 1 |
Abenavoli, E | 1 |
Di Nardo, F | 1 |
D'Arrigo, C | 1 |
Spina, E | 1 |
Zoccali, RA | 1 |
Muscatello, MR | 1 |
Egashira, N | 1 |
Abe, M | 1 |
Shirakawa, A | 1 |
Niki, T | 1 |
Mishima, K | 1 |
Iwasaki, K | 1 |
Oishi, R | 1 |
Fujiwara, M | 1 |
Ozkara, C | 1 |
Ozmen, M | 1 |
Erdogan, A | 1 |
Yalug, I | 1 |
Alkin, T | 1 |
Onur, E | 1 |
Ozerdem, A | 1 |
Buzan, RD | 1 |
Dubovsky, SL | 1 |
Kumar, TC | 1 |
Khanna, S | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Lamotrigine in the Treatment of Binge Eating Disorder Associated With Obesity: A Single-Center, Double-Blind, Placebo-Controlled, Flexible-Dose Study in Outpatients[NCT00277641] | Phase 3 | 70 participants (Anticipated) | Interventional | 2006-03-31 | Completed | ||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
2 reviews available for lamotrigine and Anankastic Personality
Article | Year |
---|---|
Pharmacological augmentation of serotonin reuptake inhibitors in patients with obsessive-compulsive disorder: A network meta-analysis.
Topics: Bayes Theorem; Drug Therapy, Combination; Granisetron; Humans; Lamotrigine; Memantine; Network Meta- | 2023 |
[Trichotillomania and comorbidity--lamotrigine in a new perspective].
Topics: Adolescent; Adult; Antidepressive Agents; Antimanic Agents; Anxiety; Behavior, Addictive; Bipolar Di | 2008 |
2 trials available for lamotrigine and Anankastic Personality
Article | Year |
---|---|
Lamotrigine in the treatment of binge-eating disorder with obesity: a randomized, placebo-controlled monotherapy trial.
Topics: Adolescent; Adult; Aged; Antimanic Agents; Body Mass Index; Bulimia Nervosa; Double-Blind Method; Fe | 2009 |
Lamotrigine augmentation of serotonin reuptake inhibitors in treatment-resistant obsessive-compulsive disorder: a double-blind, placebo-controlled study.
Topics: Adult; Aged; Anticonvulsants; Cognition; Double-Blind Method; Drug Resistance; Drug Therapy, Combina | 2012 |
12 other studies available for lamotrigine and Anankastic Personality
Article | Year |
---|---|
Lamotrigine-induced obsessive-compulsive disorder in patients with bipolar disorder.
Topics: Adult; Antipsychotic Agents; Bipolar Disorder; Diagnostic and Statistical Manual of Mental Disorders | 2019 |
Fourteen-Pound Fluvoxamine-Associated Weight Gain in a Young Woman with Depression and Multiple Anxiety Symptoms.
Topics: Adult; Anti-Anxiety Agents; Antidepressive Agents; Antidepressive Agents, Second-Generation; Anxiety | 2018 |
Obsessive-compulsive symptoms in adjunctive therapy with lamotrigine in clozapine-medicated patients.
Topics: Adult; Antipsychotic Agents; Clozapine; Cross-Sectional Studies; Drug Therapy, Combination; Female; | 2015 |
Lamotrigine Augmentation in Treatment-Resistant Pediatric Obsessive-Compulsive Disorder with a 16 Month Follow-up.
Topics: Child; Drug Therapy, Combination; Follow-Up Studies; Humans; Lamotrigine; Male; Obsessive-Compulsive | 2016 |
Lamotrigine as an augmentation agent in treatment-resistant obsessive-compulsive disorder: a case report.
Topics: Anticonvulsants; Antidepressive Agents, Tricyclic; Clomipramine; Dose-Response Relationship, Drug; D | 2010 |
Improvement of obsessive-compulsive disorder with divalproex and lamotrigine in two patients with bipolar II disorder.
Topics: Adult; Anticonvulsants; Bipolar Disorder; Female; Humans; Lamotrigine; Male; Obsessive-Compulsive Di | 2009 |
The effect of riluzole augmentation in a patient with treatment-resistant obsessive-compulsive disorder, taking two other glutaminergic agents.
Topics: Adult; Clonazepam; Drug Therapy, Combination; Excitatory Amino Acid Antagonists; Fructose; GABA Modu | 2011 |
Effects of mood stabilizers on marble-burying behavior in mice: involvement of GABAergic system.
Topics: Animals; Antipsychotic Agents; Baclofen; Behavior, Animal; Bicuculline; Carbamazepine; Dose-Response | 2013 |
Topiramate related obsessive-compulsive disorder.
Topics: Adult; Anticonvulsants; Antidepressive Agents, Second-Generation; Carbamazepine; Citalopram; Dose-Re | 2005 |
Co-occurence of blepharospasm, tourettism and obsessive-compulsive symptoms during lamotrigine treatment.
Topics: Anticonvulsants; Blepharospasm; Female; Humans; Lamotrigine; Middle Aged; Obsessive-Compulsive Disor | 2007 |
Recurrence of lamotrigine-associated rash with rechallenge.
Topics: Adult; Anticonvulsants; Bipolar Disorder; Drug Eruptions; Humans; Lamotrigine; Male; Obsessive-Compu | 1998 |
Lamotrigine augmentation of serotonin re-uptake inhibitors in obsessive-compulsive disorder.
Topics: Antidepressive Agents; Clomipramine; Dose-Response Relationship, Drug; Humans; Lamotrigine; Obsessiv | 2000 |